Interleukin-1Β interferes with epidermal homeostasis through induction of insulin resistance: Implications for psoriasis pathogenesis

Journal of Investigative Dermatology

Volumn 132, Issue 9, 2012, Pages 2206-2214

  Buerger, Claudia ^a   Richter, Beatrice ^a   Woth, Kathrin ^a   Salgo, Rebekka ^a   Malisiewicz, Bartosz ^a   Diehl, Sandra ^a   Hardt, Katja ^a   Boehncke, Sandra ^a   Boehncke, Wolf Henning ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMORBIDITY; HUMAN; HUMAN CELL; INSULIN RESISTANCE; KERATINOCYTE; MICRODIALYSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS;

EID: 84865320775     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.123     Document Type: Article

References (35)

1. Boehncke S, Thaci D, Beschmann H et al. (2007) Psoriasis patients show signs of insulin resistance. Br J Dermatol 157:1249-51
2. Boehncke WH, Boehncke S, Schon MP (2010) Managing comorbid disease in patients with psoriasis. BMJ 340:b5666
3. Boura-Halfon S, Zick Y (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 296:E581-91
4. Bovenschen HJ, Seyger MM, Van de Kerkhof PC (2005) Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation. Br J Dermatol 153:72-8
5. Calautti E, Li J, Saoncella S et al. (2005) Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem 280:32856-65
6. Cerman AA, Bozkurt S, Sav A et al. (2008) Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol 159:820-6
7. Debets R, Hegmans JP, Croughs P et al. (1997) The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol 158:2955-63
8. Faurschou A, Gniadecki R (2008) TNF-alpha stimulates Akt by a distinct aPKC-dependent pathway in premalignant keratinocytes. Exp Dermatol 17:992-7
9. Funding AT, Johansen C, Kragballe K et al. (2006) Mitogen- and stressactivated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines. J Invest Dermatol 126:1784-91
10. Gelfand JM, Troxel AB, Lewis JD et al. (2007) The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 143:1493-9
11. Goldstein DM, Kuglstatter A, Lou Y et al. (2010) Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders. J Med Chem 53:2345-53
12. Goren I, Muller E, Pfeilschifter J et al. (2006) Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha. Am J Pathol 168:765-77
13. Goren I, Muller E, Schiefelbein D et al. (2009) Akt1 controls insulin-driven VEGF biosynthesis from keratinocytes: implications for normal and diabetes-impaired skin repair in mice. J Invest Dermatol 129:752-64
14. Groves RW, Rauschmayr T, Nakamura K et al. (1996) Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1- inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease. J Clin Invest 98:336-44
15. Gupta D, Khandelwal RL (2004) Modulation of insulin effects on phosphorylation of protein kinase B and glycogen synthesis by tumor necrosis factor-alpha in HepG2 cells. Biochim Biophys Acta 1671:51-8
16. He J, Usui I, Ishizuka K et al. (2006) Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes. Mol Endocrinol 20:114-24
17. Hosotani Y, Kashiwamura S, Kimura-Shimmyo A et al. (2008) Interleukin-18 prevents apoptosis via PI3K/Akt pathway in normal human keratinocytes. J Dermatol 35:514-24
18. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860-7
19. Jager J, Gremeaux T, Cormont M et al. (2007) Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148:241-51
20. Jansson PA (2007) Endothelial dysfunction in insulin resistance and type 2 diabetes. J Intern Med 262:173-83
21. Johansen C, Funding AT, Otkjaer K et al. (2006) Protein expression of TNFalpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J Immunol 176:1431-8
22. Kearney MT, Duncan ER, Kahn M et al. (2008) Insulin resistance and endothelial cell dysfunction: studies in mammalian models. Exp Physiol 93:158-63
23. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496-509
24. Pettus LH, Wurz RP (2008) Small molecule p38 MAP kinase inhibitors for the treatment of inflammatory diseases: novel structures and developments during 2006-2008. Curr Top Med Chem 8:1452-67
25. Renne J, Schafer V, Werfel T et al. (2010) Interleukin-1 from epithelial cells fosters T cell-dependent skin inflammation. Br J Dermatol 162:1198-205
26. Sanmiguel JC, Olaru F, Li J et al. (2009) Interleukin-1 regulates keratinocyte expression of T cell targeting chemokines through interleukin-1 receptor associated kinase-1 (IRAK1) dependent and independent pathways. Cell Signal 21:685-94
27. Schinner S, Scherbaum WA, Bornstein SR et al. (2005) Molecular mechanisms of insulin resistance. Diabet Med 22:674-82
28. Semenkovich CF (2006) Insulin resistance and atherosclerosis. J Clin Invest 116:1813-22
29. Soegaard-Madsen L, Johansen C, Iversen L et al. (2010) Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement. Br J Dermatol 162: 1216-23
30. Spah F (2008) Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol 159(Suppl 2):10-7
31. Stachelscheid H, Ibrahim H, Koch L et al. (2008) Epidermal insulin/IGF-1 signalling control interfollicular morphogenesis and proliferative potential through Rac activation. EMBO J 27:2091-101
32. Taniguchi CM, Emanuelli B, Kahn CR (2006) Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7:85-96
33. Wertheimer E, Spravchikov N, Trebicz M et al. (2001) The regulation of skin proliferation and differentiation in the IR null mouse: implications for skin complications of diabetes. Endocrinology 142:1234-41
34. Wertheimer E, Trebicz M, Eldar T et al. (2000) Differential roles of insulin receptor and insulin-like growth factor-1 receptor in differentiation of murine skin keratinocytes. J Invest Dermatol 115:24-9
35. Yu XJ, Li CY, Dai HY et al. (2007) Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp Mol Pathol 83:413-8